Denmark striker Christian Eriksen collapsed in the 52nd minute of a UEFA Nations League match against Ukraine on Sunday, after his heart suddenly stopped. An implantable cardioverter defibrillator, a tiny device fitted under his skin a few months after a similar incident at the 2021 European Championship, automatically sent a shock that restored a normal heart rhythm and enabled the player to walk off the pitch.



ICDs are small, programmable pacemakers that continuously monitor a person’s heart. When a dangerous rhythm is detected, the device delivers an electrical pulse or shock to reset the heartbeat. In Eriksen’s case the shock was delivered “today” – just as the sport‑cardiologist described, it felt like a “thump in the chest,” though it saved his life.



Eriksen’s first collapse occurred in 2021 during a Euro match, and he underwent an outpatient procedure that implanted the device. The crisis in 2026 is a stark reminder of the potential for sudden cardiac arrest in young athletes – a condition that can strike without warning and kills 12 people a week under the age of 35 in the UK alone.



National screening programmes now test hearts of 14‑35‑year‑old athletes with electrocardiograms and, where needed, echocardiography. In England, every young footballer signed to a professional club must accept a heartbeat test at contract signing and again at ages 18 and 20. Roughly one in 250 athletes in the UK are found to have a heart condition that requires monitoring, and about 10 % of ICD patients receive a shock during a season of activity.



Despite the device’s presence, Eriksen is still eligible to play professional football – rules differ by country, with Italy banning play for athletes with ICDs, but many other leagues allow participation after medical clearance. The medical team must investigate why Eriksen’s heart hesitated during the match, and whether preventive measures can reduce the risk of future episodes.



Health experts stress the importance of early detection. In the 2021 incident, CPR and an external defibrillator saved Eriksen’s life on the field; the ICD now serves as an internal “shock box” that acts when a dangerous rhythm appears, a technology that is “highly effective,” says cardiology professor Aneil Malhotra.



As football fans watch the Danish National Team prepare for upcoming matches, Eriksen’s case highlights the growing intersection between advanced medical devices and high‑level sport, showing that with proper monitoring and treatment, serious heart conditions need not end athletic careers.